Dr Reddy's Subsidiary Partners with Henlius for Cancer Drug
February 6, 2025 16:24
Dr Reddy's Laboratories subsidiary signs licence agreement with Shanghai Henlius Biotech for development and commercialization of HLX15, an under-development cancer drug.
© 2026 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
